Deutsche Bank Ag\ Burning Rock Biotech LTD Transaction History

Deutsche Bank Ag\

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$6.7 - $10.23 $14,344 - $21,902	-2,141 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$9.43 - $17.14 $628,000 - $1.14 Million	-66,596 Reduced 96.89%	2,141 $20,000
Q3 2021 Nov 04, 2021	BUY	$17.37 - $27.92 $43,893 - $70,553	2,527 Added 3.82%	68,737 $1.23 Million
Q2 2021 Aug 11, 2021	BUY	$26.14 - $37.45 $1.73 Million - $2.48 Million	66,210 New	66,210 $1.95 Million

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $716M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.